Cargando…
Comparison of (99m)Tc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function
P-glycoprotein (Pgp) overexpression is a well-recognized factor in resistance to chemotherapy. Doxorubicin flow cytometry is used to monitor Pgp function in haematological specimens and biopsies from other cancers, and radionuclide imaging with sestamibi has recently shown promise for non-invasive m...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2001
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363739/ https://www.ncbi.nlm.nih.gov/pubmed/11161402 http://dx.doi.org/10.1054/bjoc.2000.1621 |